The Top 10 Most Popular Stories from NeuroNews in July 2021

Of particular interest to the readers of NeuroNews Last month.

1. Repeated clot collection attempts associated with poorer functional outcome in patients with acute ischemic stroke

Results published in Neurology showed that repeated attempts to remove blood clots are associated with an increased embolism rate in Neuland (ENT) and increased infarct growth, resulting in poorer functional outcomes in patients with acute ischemic stroke, even after successful recanalization has been achieved.

2. Research shows that new surgical technologies can help reduce brain aneurysm regrowth

According to one at the 18th Annual Society of NeuroInterventional Surgery (SNIS; July 26-29, 2021, Colorado Springs, USA and virtual).


3. Philips enrolls first patient in the WE-TRUST stroke study to evaluate a new workflow approach

Royal Philips announced the first patient enrolled in the WE-TRUST study at Vall d’Hebron University Hospital in Barcelona, ​​Spain, improving patient outcomes less than six hours after the onset of stroke.

4. Robocath, Rennes University Hospital, partners with Philips France to research stroke treatments

Robocath and Rennes University Hospital announced that they are launching a joint research program to develop robots to improve the treatment of stroke patients.

5. How stimulation is changing the future of mental health treatment

Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlined the benefits of transcranial direct current stimulation (tDCS) in the treatment of depression – and how the clinical evidence supporting its use for these and other mental health indications can be expanded in the future .

6. Mainstay Medical introduces an implantable restorative neurostimulation system in the United States

Mainstay Medical announced the limited launch in the United States of ReActiv8, its implantable restorative neurostimulation system for the treatment of persistent chronic low back pain.

7. Insightec announces approval of the focused ultrasound platform Exablate Neuro in Singapore

Insightec announced the approval of its Exablate Neuro (Exablate 4000) platform, which uses focused ultrasound to remove targets deep in the brain, by the Health Sciences Authority (HSA) in Singapore.

8. Cerenovus Unveils New Data and Innovations in Stroke Care at the SNIS Annual Meeting

Ahead of SNIS 2021, Cerenovus announced that it would showcase its latest innovations in stroke care, as well as new data during poster sessions, and showcase innovations in its ischemic and hemorrhagic portfolio to reflect its ongoing commitment to changing the course of stroke.

9. ASA underscores the value of comprehensive, patient-centered primary care after a stroke

In a new scientific opinion entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA) – a division of the American Heart Association (AHA) – has presented a roadmap for holistic, targeted and patient-centered primary care in the system for adult stroke patients.

10. Men and women respond equally well to spinal cord and DRG stimulation, despite the contrasting initial values ​​for pain

In a study to investigate gender differences in patients with Failed Back Surgery Syndrome (FBSS) or chronic visceral pain, it was shown that men and women responded equally well to SCS and dorsal root ganglion (DRG) stimulation – albeit with some differences, including “significantly lower” baseline baseline pain scores in male patients, were observed.